JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 13, 2003; DOI: 10.1124/jpet.103.052365


0022-3565/03/3063-1182-1190$20.00
JPET 306:1182-1190, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.052365v1
306/3/1182    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, K. W.
Right arrow Articles by Rhim, B. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, K. W.
Right arrow Articles by Rhim, B. Y.

CELLULAR AND MOLECULAR

Cilostazol Prevents Tumor Necrosis Factor-{alpha}-Induced Cell Death by Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Activation of Akt/Cyclic AMP Response Element-Binding Protein Phosphorylation

Ki Whan Hong, Ki Young Kim, Hwa Kyoung Shin, Jeong Hyun Lee, Jae Moon Choi, Yong-Geun Kwak, Chi Dae Kim, Won Suk Lee, and Byung Yong Rhim

Department of Pharmacology (K.W.H., K.Y.K., H.K.S., J.H.L., J.M.C., C.D.K., W.S.L., B.Y.R.), College of Medicine and Research Institute of Genetic Engineering (K.W.H.), Pusan National University, Busan, Korea; and Institute of Cardiovascular Research (Y.-G.K.), Chonbuk National University, Chonbuk, Korea

This study examines the signaling mechanism by which cilostazol prevents neuronal cell death. Cilostazol (~0.1-100 µM) prevented tumor necrosis factor-{alpha} (TNF-{alpha})-induced decrease in viability of SK-N-SH and HCN-1A cells, which was antagonized by 1 µM iberiotoxin, a maxi-K channel blocker. TNF-{alpha} did not suppress the viability of the U87-MG cell, a phosphatase and tensin homolog deleted from chromosome 10 (PTEN)-null glioblastoma cell, but it did decrease viability of U87-MG cells transfected with expression vectors for the sense PTEN, and this decrease was also prevented by cilostazol. Cilostazol as well as 1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one (NS-1619) and (3S)(+)-(5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indole-2-one (BMS 204352), maxi-K channel openers, prevented increased DNA fragmentation evoked by TNF-{alpha}, which were antagonizable by iberiotoxin. TNF-{alpha}-induced increased PTEN phosphorylation and decreased Akt/cyclic AMP response element-binding protein (CREB) phosphorylation were significantly prevented by cilostazol, those of which were antagonized by both iberiotoxin and paxilline, maxi-K channel blockers. The same results were evident in U87-MG cells transfected with expression vectors for sense PTEN. Cilostazol increases the K+ current in SK-N-SH cells by activating maxi-K channels without affecting the ATP-sensitive K+ channel. Thus, our results for the first time provide evidence that cilostazol prevents TNF-{alpha}-induced cell death by suppression of PTEN phosphorylation and activation of Akt/CREB phosphorylation via mediation of the maxi-K channel opening.


Address correspondence to: Dr. Ki Whan Hong, Department of Pharmacology, College of Medicine, Pusan National University, 10 Ami-Dong, 1-Ga, Seo-Gu, Busan 602-739, Korea. E-mail: kwhong{at}pusan.ac.kr




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C.-W. Huang, C.-C. Huang, and S.-N. Wu
Activation by Zonisamide, a Newer Antiepileptic Drug, of Large-Conductance Calcium-Activated Potassium Channel in Differentiated Hippocampal Neuron-Derived H19-7 Cells
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 98 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Y. Park, J. H. Lee, C. D. Kim, W. S. Lee, W. S. Park, J. Han, Y.-G. Kwak, K. Y. Kim, and K. W. Hong
Cilostazol Suppresses Superoxide Production and Expression of Adhesion Molecules in Human Endothelial Cells via Mediation of cAMP-Dependent Protein Kinase-Mediated Maxi-K Channel Activation
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1238 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. Lee, G. T. Oh, S. Y. Park, J.-H. Choi, J.-G. Park, C. D. Kim, W. S. Lee, B. Y. Rhim, Y. W. Shin, and K. W. Hong
Cilostazol Reduces Atherosclerosis by Inhibition of Superoxide and Tumor Necrosis Factor-{alpha} Formation in Low-Density Lipoprotein Receptor-Null Mice Fed High Cholesterol
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 502 - 509.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Y. Park, J. H. Lee, Y. K. Kim, C. D. Kim, B. Y. Rhim, W. S. Lee, and K. W. Hong
Cilostazol Prevents Remnant Lipoprotein Particle-Induced Monocyte Adhesion to Endothelial Cells by Suppression of Adhesion Molecules and Monocyte Chemoattractant Protein-1 Expression via Lectin-Like Receptor for Oxidized Low-Density Lipoprotein Receptor Activation
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1241 - 1248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-W. Lin, S.-R. Yang, M.-H. Huang, and S.-N. Wu
Stimulatory Actions of Caffeic Acid Phenethyl Ester, a Known Inhibitor of NF-{kappa}B Activation, on Ca2+-activated K+ Current in Pituitary GH3 Cells
J. Biol. Chem., June 25, 2004; 279(26): 26885 - 26892.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. H. Lee, K. Y. Kim, Y.-K. Lee, S. Y. Park, C. D. Kim, W. S. Lee, B. Y. Rhim, and K. W. Hong
Cilostazol Prevents Focal Cerebral Ischemic Injury by Enhancing Casein Kinase 2 Phosphorylation and Suppression of Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation in Rats
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 896 - 903.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S.-N. Wu, S.-I. Liu, and M.-H. Huang
Cilostazol, an Inhibitor of Type 3 Phosphodiesterase, Stimulates Large-Conductance, Calcium-Activated Potassium Channels in Pituitary GH3 Cells and Pheochromocytoma PC12 Cells
Endocrinology, March 1, 2004; 145(3): 1175 - 1184.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Y. Kim, H. K. Shin, J. H. Lee, C. D. Kim, W. S. Lee, B. Y. Rhim, Y. W. Shin, and K. W. Hong
Cilostazol Enhances Casein Kinase 2 Phosphorylation and Suppresses Tumor Necrosis Factor-{alpha}-Induced Increased Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation and Apoptotic Cell Death in SK-N-SH Cells
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 97 - 104.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.